| GRI index - Labor Practices & Decent Work | |||||
| Indicator | Level of fulfilment | Where to find the indicator | Corresponding principle in Global Compact | Com- ment | |
| LA1 Total workforce by employment type, employment contract, and region. | - | Web: Interactive charts Web: Facts and figures | 6 | ||
| LA2 Total number and rate of employee turnover by age group, gender, and region. | + | Web: Interactive charts | 6 | ||
| LA3 Benefits provided to full-time employees that are not provided to temporary or part-time employees, by major operations. | - | Web: Wages and benefits | 6 | ||
| LA4 Percentage of employees covered by collective bargaining agreements. | + | Web: Wages and benefits | 3 | ||
| LA5 Minimum notice period(s) regarding significant operational changes, including whether it is specified in collective agreements. | - | 3 | |||
| LA6 Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs. | + | 6 | |||
| LA7 Rates of injury, occupational diseases, lost days, and absenteeism, and total number of work-related fatalities by region. | + | AR07 pp. 89-99: Consolidated non-financial statements Web: Interactive charts | 6 | ||
| LA8 Education, training, counseling, prevention, and risk-control programs in place to assist workforce members, their families, or community members regarding serious diseases. | + | Web: Employee health | 6 | ||
| LA9 Health and safety topics covered in formal agreements with trade unions.Health and safety topics covered in formal agreements with trade unions. | + | 3 | |||
| LA10 Average hours of training per year per employee by employee category. | - | 6 | |||
| LA11 Programs for skills management and lifelong learning that support the continued employability of employees and assist them in managing career endings. | + | AR07 p. 25: People put values to work Web: People Strategy | 6 | ||
| LA12 Percentage of employees receiving regular performance and career development reviews. | + | Web: People Strategy Web: Talent development | 6 | ||
| LA13 Composition of governance bodies and breakdown of employees per category according to gender, age group, minority group membership, and other indicators of diversity. | + | AR07 pp. 44-45: Executive remuneration. AR07 pp. 89-99: Consolidated non-financial statements Web: Interactive charts | 6 | ||
| LA14 Ratio of basic salary of men to women by employee category. | - | 6 | |||
Exclusively for Health Care Professionals. Stay up to date on Novo Nordisk diabetes products: Victoza®, Levemir®, NovoMix®, NovoRapid® and Devices, and read about current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients.
Overview
NovoSeven®
270 µg/kg dose
Room temperature stable
8 mg vial
Management
Blood coagulation
Key papers
Treatment guidelines
Services & links
WFH patients'
leaflet
Patient story
Congenital haemophilia
Acquired haemophilia
Factor VII deficiency
Glanzmann's
thrombasthenia
Overview
GHD (Growth hormone deficiency)
GHDA (Growth hormone deficiency) in adults
SGA (Small for gestational age)
Turner syndrome
Noonan syndrome
Skeletal dysplasia
Chronic renal disease
Norditropin®
Norditropin® FlexPro®
Norditropin NordiFlex®
NordiFlex PenMate®
NordiPen® with Norditropin® SimpleXx®
NordiPenMate®
Norditropin® NordiLet®
NovoFine®
NordiNet® (outcomes registry)
NordiScience® (HCP support)
NordiCare® (Patient support)
Our partnership with Save the Children
Testimonials
Overview
Introduction
Activelle®
Eviana®
Novofem®
Estrofem®
Vagifem®
Convenience & compliance
Our history in HRT
Introduction
Symptoms & complaints
Duration of treatment
Oestrogen
Progestogen
Continuous combined HRT
Sequential combined HRT
Low-dose HRT
According to applicable law, only Health Care Professionals are allowed to access the product information in this section.
Information for patients and relatives
Do you have a recent master degree, and do you want a successful career in one of the world's leading pharmaceutical companies? If yes, then the Novo Nordisk Graduate Programme is what you are looking for.
Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 31,400 employees in 74 countries, and markets its products in 179 countries.
Novo Nordisks B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).








